Biomedical Engineering
Technological advances exploited to engineer cardiac tissue
Published in Blood Weekly, May 5th, 2005
According to a recent review from Israel, "Unlike heart valves or blood vessels, heart muscle has no replacement alternatives. The most challenging goal in the field of cardiovascular tissue engineering is the creation/ regeneration of an engineered heart muscle."
"Recent advances in methods of stem cell isolation, culture in bioreactors, and the synthesis of bioactive materials promise to create engineered cardiac tissue ex vivo.
"At the same time, new approaches arc conceived that explore ways to induce tissue regeneration after injury," said J. Leor and coworkers...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2005-05-05)
More Articles from Blood Weekly
- Osteopetrosis
High peripheral blood SCs enable autologous backup before SCT for osteopetrosis - Stem Cell Transplantation
ABO incompatibility does not affect clinical outcome after APBSCT - Stem Cell Transplantation
Circulating DC subsets post-ASCT correlate with acute GVHD severity in children - Tissue Engineering
Bovine collagen constructs used to reconstruct full-thickness scalp defects - Acinetobacter Outbreaks
Acinetobacter baumannii nosocomial outbreak strain produces PER-1 ESBL - African Swine Fever
Invader assay adapted for African swine fever virus DNA detection - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
